Advertisement

Journal of Radioanalytical and Nuclear Chemistry

, Volume 188, Issue 6, pp 439–451 | Cite as

Methods of assessment of atropine and scopolamine levels in transdermal permeation

  • V. Koprda
  • P. Bohov
  • J. Smisterová
  • L. Boháčik
Article

Abstract

Three methods of atropine and scopolamine determination in transdermal permeation have been developed. Radiometric determination seems to be an excellent, quick and extremely sensitive method, which ought to be preferred when working with biological systems. The radioreceptor analysis is of group specificity. It can be used to advantage in monitoring atropine plasma concentrations exceeding 1.5 ng cm−3 and scopolamine concentrations above 50 pg cm−3. GC/MS provides adequate specificity and sensitivity for the determination of therapeutic levels of atropine and scopolamine in blood. The sensitivity of this method is approximately 1–2 ng cm−3.

Keywords

Physical Chemistry Inorganic Chemistry Plasma Concentration Biological System Atropine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Y. Horimoto, M. Naide,Canad. J. Anaesth., 37 (1990) 94.Google Scholar
  2. 2.
    P. Semple, T. H. Madej, R. G. Wheatley, I. J. Jackson, J. Stevens,Anaesthesia, 47 (1992) 399.Google Scholar
  3. 3.
    J. How, P. Lee, L. C. Seet, P. K. Tan,Aviat. Space Environ. Med., 59 (1988) 646.Google Scholar
  4. 4.
    L. Brown, R. Langer,Ann. Rew. Med., 39 (1988) 221.Google Scholar
  5. 5.
    C. T. Richardson, M. Feldman,Gut, 27 (1986) 1493.Google Scholar
  6. 6.
    R. H. Guy, J. Hadgraft,J. Control. Rel., 1 (1985) 177.Google Scholar
  7. 7.
    R. H. Guy, J. Hadgraft, D. A. Bucks,Xenobiotica, 17 (1987) 325.Google Scholar
  8. 8.
    P. H. Hinderling, U. Gundert-Remy, O. Schmidlin,J. Pharm. Sci., 74 (1985) 703.Google Scholar
  9. 9.
    P. H. Hinderling, U. Gundert-Remy, O. Schmidlin,J. Pharm. Sci., 74 (1985) 711.Google Scholar
  10. 10.
    V. Koprda, et al.: Study of Auxiliary Pharmaceutical Substances, New Forms of Drugs and Transdermal Therapeutic Systems (Report, In Slovak), Bratislava, UEF SAV, 1990.Google Scholar
  11. 11.
    R. J. Lefkowitz, J. Roth, I. Tastan,Science, 170 (1970) 633.Google Scholar
  12. 12.
    J. Šmisterová,Farm. Obz., 61 (1992) 193.Google Scholar
  13. 13.
    K. Ensing, R. A. De Zeeuw,Pharm. Res., 3 (1986) 327.Google Scholar
  14. 14.
    D. H. Lowry, N. J. Rosenbough, A. L. Ferr, R. J. Randall,J. Biol. Chem., 193 (1951) 265.Google Scholar
  15. 15.
    R. Wunderwald, G. Jurz, G. Michal,Anal. Biochem., 59 (1974) 468.Google Scholar
  16. 16.
    K. Ensing, K. G. Feitoma, W. G. Bloemhof, R. A. De Zeeuw,J. Biomed. Biophys. Meth., 13 (1986) 85.Google Scholar
  17. 17.
    R. F. Metcalfe,Biochem. Pharmacol., 130 (1980) 209.Google Scholar
  18. 18.
    L. Stoll, P. Flackenstein, D. Riemen, W. E. Muller,Res. Com. Chem. Pathol. Pharmacol., 64 (1989) 59.Google Scholar
  19. 19.
    W. F. Bayne, F. T. Tao, N. Crisologo,J. Pharm. Sci., 64 (1975) 288.Google Scholar
  20. 20.
    M. Eckert, P. H. Hinderling,Agents Actions, 11 (1981) 520.Google Scholar
  21. 21.
    J. Saady, A. Poklis,J. Anal. Toxicol., 13 (1989) 296.Google Scholar

Copyright information

© Akadémiai Kiadó 1994

Authors and Affiliations

  • V. Koprda
    • 1
  • P. Bohov
    • 1
  • J. Smisterová
    • 1
  • L. Boháčik
    • 1
  1. 1.Institute of Experimental PharmacologySlovak Academy of SciencesBratislavaSlovak Republic

Personalised recommendations